21 results on '"Witte, Daniel R."'
Search Results
2. Insulin Resistance Is Accompanied by Increased Fasting Glucagon and Delayed Glucagon Suppression in Individuals With Normal and Impaired Glucose Regulation.
- Author
-
Færch K, Vistisen D, Pacini G, Torekov SS, Johansen NB, Witte DR, Jonsson A, Pedersen O, Hansen T, Lauritzen T, Jørgensen ME, Ahrén B, and Holst JJ
- Subjects
- Aged, Blood Glucose metabolism, Cohort Studies, Diabetes Mellitus, Type 2 blood, Diabetes Mellitus, Type 2 metabolism, Fasting blood, Female, Glucose Tolerance Test, Humans, Insulin blood, Male, Middle Aged, Prediabetic State blood, Prediabetic State metabolism, Glucagon blood, Glucose metabolism, Insulin Resistance physiology
- Abstract
Hyperinsulinemia is an adaptive mechanism that enables the maintenance of normoglycemia in the presence of insulin resistance. We assessed whether glucagon is also involved in the adaptation to insulin resistance. A total of 1,437 individuals underwent an oral glucose tolerance test with measurements of circulating glucose, insulin, and glucagon concentrations at 0, 30 and 120 min. Early glucagon suppression was defined as suppression in the period from 0 to 30 min, and late glucagon suppression as 30 to 120 min after glucose intake. Insulin sensitivity was estimated by the validated insulin sensitivity index. Individuals with screen-detected diabetes had 30% higher fasting glucagon levels and diminished early glucagon suppression, but greater late glucagon suppression when compared with individuals with normal glucose tolerance (P ≤ 0.014). Higher insulin resistance was associated with higher fasting glucagon levels, less early glucagon suppression, and greater late glucagon suppression (P < 0.001). The relationship between insulin sensitivity and fasting glucagon concentrations was nonlinear (P < 0.001). In conclusion, increased fasting glucagon levels and delayed glucagon suppression, together with increased circulating insulin levels, develop in parallel with insulin resistance. Therefore, glucose maintenance during insulin resistance may depend not only on hyperinsulinemia but also on the ability to suppress glucagon early after glucose intake., (© 2016 by the American Diabetes Association.)
- Published
- 2016
- Full Text
- View/download PDF
3. Physical activity energy expenditure vs cardiorespiratory fitness level in impaired glucose metabolism.
- Author
-
Lidegaard LP, Hansen AL, Johansen NB, Witte DR, Brage S, Lauritzen T, Jørgensen ME, Christensen DL, and Færch K
- Subjects
- Adult, Aged, Anaerobic Threshold, Blood Glucose metabolism, Body Composition, Cardiovascular Physiological Phenomena, Cohort Studies, Cross-Sectional Studies, Diabetes Mellitus, Type 2 metabolism, Female, Glucose Intolerance metabolism, Glucose Tolerance Test, Humans, Insulin Resistance, Longitudinal Studies, Male, Middle Aged, Energy Metabolism, Glucose metabolism, Physical Fitness
- Abstract
Aim/hypothesis: Little is known about the relative roles of physical activity energy expenditure (PAEE) and cardiorespiratory fitness (CRF) as determinants of glucose regulation. The aim of this study was to examine the associations of PAEE and CRF with markers of glucose metabolism, and to test the hypothesis that CRF modifies the association between PAEE and glucose metabolism., Methods: We analysed cross-sectional data from 755 adults from the Danish ADDITION-PRO study. On the basis of OGTT results, participants without known diabetes were classified as having normal glucose tolerance, isolated impaired fasting glycaemia (i-IFG), isolated impaired glucose tolerance (i-IGT), combined IFG + IGT or screen-detected diabetes mellitus. Markers of insulin sensitivity and beta cell function were determined. PAEE was measured using a combined heart rate and movement sensor. CRF (maximal oxygen uptake) was estimated using a submaximal 8 min step test. The associations were examined by linear regression analysis. Results were adjusted for relevant confounders., Results: PAEE and CRF were reduced in individuals with i-IGT, combined IFG + IGT and screen-detected diabetes mellitus, but were not significantly different in individuals with i-IFG compared with those with normal glucose tolerance. When adjusting CRF for PAEE and vice versa, PAEE and CRF were both associated with lower fasting and 2 h insulin and higher peripheral insulin sensitivity. CRF was additionally associated with lower fasting and 2 h glucose and higher insulin sensitivity and beta cell function. There was no interaction between CRF and PAEE for any markers of glucose metabolism., Conclusions/interpretation: Only CRF, not PAEE, appears to be independently associated with plasma glucose levels and beta cell function, suggesting that CRF may be particularly important for glycaemic control.
- Published
- 2015
- Full Text
- View/download PDF
4. The effect of FOXA2 rs1209523 on glucose-related phenotypes and risk of type 2 diabetes in Danish individuals.
- Author
-
Banasik K, Hollensted M, Andersson E, Sparsø T, Sandbaek A, Lauritzen T, Jørgensen T, Witte DR, Pedersen O, and Hansen T
- Subjects
- Adult, Blood Glucose analysis, Case-Control Studies, Denmark, Diabetes Mellitus, Type 2 metabolism, Female, Genetic Predisposition to Disease, Genetic Variation, Genome-Wide Association Study, Genotype, Glucose genetics, Glucose Tolerance Test, Humans, Insulin metabolism, Insulin Secretion, Male, Middle Aged, Polymerase Chain Reaction, Polymorphism, Single Nucleotide, Risk, Diabetes Mellitus, Type 2 genetics, Glucose metabolism, Hepatocyte Nuclear Factor 3-beta genetics, Insulin Resistance genetics
- Abstract
Background: Variations within the FOXA family have been studied for a putative contribution to the risk of type 2 diabetes (T2D), and recently the minor T-allele of FOXA2 rs1209523 was reported to associate with decreased fasting plasma glucose levels in a study using a weighted false discovery rate control procedure to enhance the statistical power of genome wide association studies in detecting associations between low-frequency variants and a given trait.Thus, the primary aim of this study was to investigate whether the minor T-allele of rs1205923 in FOXA2 associated with 1) decreased fasting plasma glucose and 2) a lower risk of developing T2D. Secondly, we investigated whether rs1205923 in FOXA2 associated with other glucose-related phenotypes., Methods: The variant was genotyped in Danish individuals from four different study populations using KASPar(®) PCR SNP genotyping system. We examined for associations of the FOXA2 genotype with fasting plasma glucose and estimates of insulin release and insulin sensitivity following an oral glucose tolerance test in 6,162 Danish individuals from the population-based Inter99 study while association with T2D risk was assessed in 10,196 Danish individuals including four different study populations., Results: The FOXA2 rs1209523 was not associated with fasting plasma glucose (effect size (β) = -0.03 mmol/l (95%CI: -0.07; 0.01), p = 0.2) in glucose-tolerant individuals from the general Danish population. Furthermore, when employing a case-control setting the variant showed no association with T2D (odds ratio (OR) = 0.82 (95%CI: 0.62-1.07), p = 0.1) among Danish individuals. However, when we performed the analysis in a subset of 6,022 non-obese individuals (BMI < 30 kg/m(2)) an association with T2D was observed (OR = 0.68 (95%CI: 0.49-0.94), p = 0.02). Also, several indices of insulin release and β-cell function were associated with the minor T-allele of FOXA2 rs1209523 in non-obese individuals., Conclusions: We failed to replicate association of the minor T-allele of FOXA2 rs1209523 with fasting plasma glucose in a population based sample of glucose tolerant individuals. More extensive studies are needed in order to fully elucidate the potential role of FOXA2 in glucose homeostasis.
- Published
- 2012
- Full Text
- View/download PDF
5. The effect of PCSK1 variants on waist, waist-hip ratio and glucose metabolism is modified by sex and glucose tolerance status.
- Author
-
Gjesing AP, Vestmar MA, Jørgensen T, Heni M, Holst JJ, Witte DR, Hansen T, and Pedersen O
- Subjects
- Adipose Tissue, Adult, Alleles, Anthropometry methods, Cohort Studies, Denmark, Female, Genotype, Glucose Tolerance Test, Humans, Male, Middle Aged, Obesity genetics, Sex Factors, Waist-Hip Ratio, Gene Expression Regulation, Enzymologic, Glucose metabolism, Proprotein Convertase 1 genetics, Proprotein Convertase 1 physiology
- Abstract
Background: We aimed to evaluate the effects of the G-allele of rs6232 and the C-allele of rs6235 within PCSK1 on measures of body fat and glucose homeostasis in Danish individuals and to assess interactions of genotypes with age, sex and glucose tolerance status. Data were included in meta-analyses of additional Europeans., Methodology/principal Findings: Rs6232 and rs6235 were genotyped in 6,164 Danes from the Inter99 study of middle-aged people. Results from these analyses were combined with previously published studies in meta-analyses of a total of 27,786 individuals. The impact of the variants was also investigated in a subset of 62 glucose-tolerant men during a meal challenge including measures of serum incretins. In men we found an effect on body composition in sex-stratified analyses where the rs6235 C-allele conferred an increased waist circumference of 0.8 cm per allele (0.2-1.5, p = 0.008) and increased waist-to-hip ratio of 0.004 (0.0005-0.008, p = 0.027). In the meta-analyses where men and women were combined, the rs6232 G-allele associated with increased waist-to-hip ratio (p = 0.02) and the rs6235 C-allele associated with increased waist circumference (p = 0.01). Furthermore, the rs6235 C-allele was associated nominally with a 0.6% (0.1-1%, p = 0.01) reduction in fasting glucose, it interacted with glucose tolerance status for traits related to glucose metabolism and analysis among individuals having abnormal glucose tolerance revealed a 5% (-0.7-9%, p = 0.02) elevated level of acute insulin response for this variant. Finally, we found that the rs6232 G-allele associated with higher levels of GLP-1, GLP-2 and glucagon and that the rs6235 C-allele associated with higher levels of GIP and glucagon during a meal-test., Conclusions/significance: PCSK1 rs6232 G-allele and rs6235 C-allele have an effect on body composition which may be modified by sex, whereas the effect of rs6235 C-allele on fasting and stimulated circulating plasma glucose and hormone levels may be influenced by glucose tolerance status.
- Published
- 2011
- Full Text
- View/download PDF
6. Genome-wide association study and functional characterization identifies candidate genes for insulin-stimulated glucose uptake
- Author
-
Williamson, Alice, Norris, Dougall M, Yin, Xianyong, Broadaway, K Alaine, Moxley, Anne H, Vadlamudi, Swarooparani, Wilson, Emma P, Jackson, Anne U, Ahuja, Vasudha, Andersen, Mette K, Arzumanyan, Zorayr, Bonnycastle, Lori L, Bornstein, Stefan R, Bretschneider, Maxi P, Buchanan, Thomas A, Chang, Yi-Cheng, Chuang, Lee-Ming, Chung, Ren-Hua, Clausen, Tine D, Damm, Peter, Delgado, Graciela E, de Mello, Vanessa D, Dupuis, Josée, Dwivedi, Om P, Erdos, Michael R, Silva, Lilian Fernandes, Frayling, Timothy M, Gieger, Christian, Goodarzi, Mark O, Guo, Xiuqing, Gustafsson, Stefan, Hakaste, Liisa, Hammar, Ulf, Hatem, Gad, Herrmann, Sandra, Højlund, Kurt, Horn, Katrin, Hsueh, Willa A, Hung, Yi-Jen, Hwu, Chii-Min, Jonsson, Anna, Kårhus, Line L, Kleber, Marcus E, Kovacs, Peter, Lakka, Timo A, Lauzon, Marie, Lee, I-Te, Lindgren, Cecilia M, Lindström, Jaana, Linneberg, Allan, Liu, Ching-Ti, Luan, Jian’an, Aly, Dina Mansour, Mathiesen, Elisabeth, Moissl, Angela P, Morris, Andrew P, Narisu, Narisu, Perakakis, Nikolaos, Peters, Annette, Prasad, Rashmi B, Rodionov, Roman N, Roll, Kathryn, Rundsten, Carsten F, Sarnowski, Chloé, Savonen, Kai, Scholz, Markus, Sharma, Sapna, Stinson, Sara E, Suleman, Sufyan, Tan, Jingyi, Taylor, Kent D, Uusitupa, Matti, Vistisen, Dorte, Witte, Daniel R, Walther, Romy, Wu, Peitao, Xiang, Anny H, Zethelius, Björn, Ahlqvist, Emma, Bergman, Richard N, Chen, Yii-Der Ida, Collins, Francis S, Fall, Tove, Florez, Jose C, Fritsche, Andreas, Grallert, Harald, Groop, Leif, Hansen, Torben, Koistinen, Heikki A, Komulainen, Pirjo, Laakso, Markku, Lind, Lars, Loeffler, Markus, März, Winfried, Meigs, James B, Raffel, Leslie J, Rauramaa, Rainer, Rotter, Jerome I, Schwarz, Peter EH, and Stumvoll, Michael
- Subjects
Biochemistry and Cell Biology ,Genetics ,Biological Sciences ,Diabetes ,Clinical Research ,Human Genome ,Prevention ,Nutrition ,2.1 Biological and endogenous factors ,Aetiology ,5.1 Pharmaceuticals ,Development of treatments and therapeutic interventions ,Metabolic and endocrine ,Humans ,Insulin ,Genome-Wide Association Study ,Insulin Resistance ,Diabetes Mellitus ,Type 2 ,Glucose ,Blood Glucose ,Meta-Analysis of Glucose and Insulin-related Traits Consortium ,Medical and Health Sciences ,Developmental Biology ,Agricultural biotechnology ,Bioinformatics and computational biology - Abstract
Distinct tissue-specific mechanisms mediate insulin action in fasting and postprandial states. Previous genetic studies have largely focused on insulin resistance in the fasting state, where hepatic insulin action dominates. Here we studied genetic variants influencing insulin levels measured 2 h after a glucose challenge in >55,000 participants from three ancestry groups. We identified ten new loci (P
- Published
- 2023
7. Trajectories of glycaemia, insulin sensitivity and insulin secretion in South Asian and white individuals before diagnosis of type 2 diabetes: a longitudinal analysis from the Whitehall II cohort study
- Author
-
Hulman, Adam, Simmons, Rebecca K., Brunner, Eric J., Witte, Daniel R., Færch, Kristine, Vistisen, Dorte, Ikehara, Satoyo, Kivimaki, Mika, and Tabák, Adam G.
- Published
- 2017
- Full Text
- View/download PDF
8. Sex differences in glucose and insulin trajectories prior to diabetes diagnosis: the Whitehall II study
- Author
-
Vistisen, Dorte, Witte, Daniel R., Tabák, Adam G., Brunner, Eric J., Kivimäki, Mika, and Færch, Kristine
- Published
- 2014
- Full Text
- View/download PDF
9. Combined heart rate- and accelerometer-assessed physical activity energy expenditure and associations with glucose homeostasis markers in a population at high risk of developing diabetes: The ADDITION-PRO study
- Author
-
Hansen, Anne-Louise S., Carstensen, Bendix, Helge, Jorn W., Johansen, Nanna B., Gram, Bibi, Christiansen, Jens S., Brage, Soren, Lauritzen, Torsten, Jorgensen, Marit E., Aadahl, Mette, and Witte, Daniel R.
- Subjects
Glucose tolerance tests ,Dextrose ,Heart beat ,Homeostasis ,Glucose ,Glucose metabolism ,Type 2 diabetes -- Risk factors -- Research ,Health - Abstract
OBJECTIVE--Regular physical activity (PA) reduces the risk of developing type 2 diabetes, and different subtypes of dysglycemia have shown different associations with PA. To better understand the associations of PA [...]
- Published
- 2013
- Full Text
- View/download PDF
10. Associations of Mitochondrial and Nuclear Mitochondrial Variants and Genes with Seven Metabolic Traits
- Author
-
Kraja, Aldi T, Liu, Chunyu, Fetterman, Jessica L, Graff, Mariaelisa, Have, Christian Theil, Gu, Charles, Yanek, Lisa R, Feitosa, Mary F, Arking, Dan E, Chasman, Daniel I, Young, Kristin, Ligthart, Symen, Hill, W David, Weiss, Stefan, Luan, Jian'an, Giulianini, Franco, Li-Gao, Ruifang, Hartwig, Fernando P, Lin, Shiow J, Wang, Lihua, Richardson, Tom G, Yao, Jie, Fernandez, Eliana P, Ghanbari, Mohsen, Wojczynski, Mary K, Lee, Wen-Jane, Argos, Maria, Armasu, Sebastian M, Barve, Ruteja A, Ryan, Kathleen A, An, Ping, Baranski, Thomas J, Bielinski, Suzette J, Bowden, Donald W, Broeckel, Ulrich, Christensen, Kaare, Chu, Audrey Y, Corley, Janie, Cox, Simon R, Uitterlinden, Andre G, Rivadeneira, Fernando, Cropp, Cheryl D, Daw, E Warwick, Van Heemst, Diana, De Las Fuentes, Lisa, Gao, He, Tzoulaki, Ioanna, Ahluwalia, Tarunveer S, De Mutsert, Renée, Emery, Leslie S, Erzurumluoglu, A Mesut, Perry, James A, Fu, Mao, Forouhi, Nita G, Gu, Zhenglong, Hai, Yang, Harris, Sarah E, Hemani, Gibran, Hunt, Steven C, Irvin, Marguerite R, Jonsson, Anna E, Justice, Anne E, Kerrison, Nicola D, Larson, Nicholas B, Lin, Keng-Hung, Love-Gregory, Latisha D, Mathias, Rasika A, Lee, Joseph H, Nauck, Matthias, Noordam, Raymond, Ong, Ken K, Pankow, James, Patki, Amit, Pattie, Alison, Petersmann, Astrid, Qi, Qibin, Ribel-Madsen, Rasmus, Rohde, Rebecca, Sandow, Kevin, Schnurr, Theresia M, Sofer, Tamar, Starr, John M, Taylor, Adele M, Teumer, Alexander, Timpson, Nicholas J, De Haan, Hugoline G, Wang, Yujie, Weeke, Peter E, Williams, Christine, Wu, Hongsheng, Yang, Wei, Zeng, Donglin, Witte, Daniel R, Weir, Bruce S, Wareham, Nicholas J, Vestergaard, Henrik, Turner, Stephen T, Torp-Pedersen, Christian, Stergiakouli, Evie, Sheu, Wayne Huey-Herng, Rosendaal, Frits R, Ikram, M Arfan, Franco, Oscar H, Ridker, Paul M, Perls, Thomas T, Pedersen, Oluf, Nohr, Ellen A, Newman, Anne B, Linneberg, Allan, Langenberg, Claudia, Kilpeläinen, Tuomas O, Kardia, Sharon LR, Jørgensen, Marit E, Jørgensen, Torben, Sørensen, Thorkild IA, Homuth, Georg, Hansen, Torben, Goodarzi, Mark O, Deary, Ian J, Christensen, Cramer, Chen, Yii-Der Ida, Chakravarti, Aravinda, Brandslund, Ivan, Bonnelykke, Klaus, Taylor, Kent D, Wilson, James G, Rodriguez, Santiago, Davies, Gail, Horta, Bernardo L, Thyagarajan, Bharat, Rao, DC, Grarup, Niels, Davila-Roman, Victor G, Hudson, Gavin, Guo, Xiuqing, Arnett, Donna K, Hayward, Caroline, Vaidya, Dhananjay, Mook-Kanamori, Dennis O, Tiwari, Hemant K, Levy, Daniel, Loos, Ruth JF, Dehghan, Abbas, Elliott, Paul, Malik, Afshan N, Scott, Robert A, Becker, Diane M, De Andrade, Mariza, Province, Michael A, Meigs, James B, Rotter, Jerome I, North, Kari E, Epidemiology, Internal Medicine, Gastroenterology & Hepatology, Home Office, Medical Research Council (MRC), National Institute for Health Research, Imperial College Healthcare NHS Trust- BRC Funding, UK DRI Ltd, Luan, Jian'an [0000-0003-3137-6337], Erzurumluoglu, Mesut [0000-0003-1322-8138], Forouhi, Nita [0000-0002-5041-248X], Ong, Kenneth [0000-0003-4689-7530], Wareham, Nicholas [0000-0003-1422-2993], Langenberg, Claudia [0000-0002-5017-7344], and Apollo - University of Cambridge Repository
- Subjects
insulin ,HbA1c ,MT-nDNA candidate genes ,SUSCEPTIBILITY LOCI ,Quantitative Trait Loci ,610 Medicine & health ,ATHEROSCLEROSIS RISK ,waist-to-hip ratio ,PERIPHERAL-BLOOD ,DNA, Mitochondrial ,Article ,HOMA-IR ,Body Mass Index ,Cohort Studies ,BMI ,360 Social problems & social services ,Adipocytes ,Diabetes Mellitus ,GLYCEMIC TRAITS ,Humans ,INDIVIDUALS REVEAL ,GENOME-WIDE ASSOCIATION ,glucose ,Glycated Hemoglobin ,Genetics & Heredity ,Science & Technology ,Waist-Hip Ratio ,mtDNA ,Genetic Variation ,COMMON VARIANTS ,HOMA-B ,11 Medical And Health Sciences ,DNA COPY NUMBER ,06 Biological Sciences ,BODY-MASS INDEX ,mitochondria ,Genes, Mitochondrial ,Metabolism ,ADIPOSE-TISSUE ,Cardiovascular Diseases ,Life Sciences & Biomedicine - Abstract
Mitochondria (MT), the major site of cellular energy production, are under dual genetic control by 37 mitochondrial DNA (mtDNA) genes and numerous nuclear genes (MT-nDNA). In the CHARGEmtDNA+ Consortium, we studied genetic associations of mtDNA and MT-nDNA associations with body mass index (BMI), waist-hip-ratio (WHR), glucose, insulin, HOMA-B, HOMA-IR, and HbA1c. This 45-cohort collaboration comprised 70,775 (insulin) to 170,202 (BMI) pan-ancestry individuals. Validation and imputation of mtDNA variants was followed by single-variant and gene-based association testing. We report two significant common variants, one in MT-ATP6 associated (p ≤ 5E-04) with WHR and one in the D-loop with glucose. Five rare variants in MT-ATP6, MT-ND5, and MT-ND6 associated with BMI, WHR, or insulin. Gene-based meta-analysis identified MT-ND3 associated with BMI (p ≤ 1E-03). We considered 2,282 MT-nDNA candidate gene associations compiled from online summary results for our traits (20 unique studies with 31 dataset consortia's genome-wide associations [GWASs]). Of these, 109 genes associated (p ≤ 1E-06) with at least 1 of our 7 traits. We assessed regulatory features of variants in the 109 genes, cis- and trans-gene expression regulation, and performed enrichment and protein-protein interactions analyses. Of the identified mtDNA and MT-nDNA genes, 79 associated with adipose measures, 49 with glucose/insulin, 13 with risk for type 2 diabetes, and 18 with cardiovascular disease, indicating for pleiotropic effects with health implications. Additionally, 21 genes related to cholesterol, suggesting additional important roles for the genes identified. Our results suggest that mtDNA and MT-nDNA genes and variants reported make important contributions to glucose and insulin metabolism, adipocyte regulation, diabetes, and cardiovascular disease.
- Published
- 2019
11. Hyperglycemia, type 2 diabetes, and depressive symptoms: the British Whitehall II study
- Author
-
Kivimaki, Mika, Tabak, Adam G., Batty, G. David, Singh-Manoux, Archana, Akbaraly, Tasnime N., Witte, Daniel R., Brunner, Eric J., Marmot, Michael G., and Lawlor, Debbie A.
- Subjects
Dextrose ,Depression, Mental -- Diagnosis ,Glucose ,Type 2 diabetes -- Diagnosis ,Hyperglycemia -- Diagnosis ,Health - Abstract
OBJECTIVE--To examine the recent suggestion that impaired fasting glucose may protect against depression, whereas a diagnosis of diabetes might then result in depression. RESEARCH DESIGN AND METHODS--Cross-sectional analysis of 4,228 [...]
- Published
- 2009
12. Assessment of time to glucose peak during an oral glucose tolerance test.
- Author
-
Hulman, Adam, Witte, Daniel R., Vistisen, Dorte, and Færch, Kristine
- Subjects
- *
GLUCOSE tolerance tests , *CURVES , *GLUCOSE , *STATISTICAL software , *LOGISTIC regression analysis - Abstract
The article focuses on a study on assessment of time to glucose peak during an oral glucose tolerance test (OGTT). Topics discussed include understanding of features of the glucose curve through analysis of OGTT, extracting individual-specific parameters from the model with statistical software, and comparing the predictive ability of the binary and the continuous time to glucose peak variables using logistic regression.
- Published
- 2017
- Full Text
- View/download PDF
13. Trajectories of cardiometabolic risk factors before diagnosis of three subtypes of type 2 diabetes: a post-hoc analysis of the longitudinal Whitehall II cohort study.
- Author
-
Færch, Kristine, Witte, Daniel R., Tabák, Adam G., Perreault, Leigh, Herder, Christian, Brunner, Eric], Kivimäki, Mika, and Vistisen, Dorte
- Subjects
- *
TYPE 2 diabetes , *DIABETES , *CARDIOVASCULAR diseases risk factors , *ENDOCRINE diseases , *GLUCOSE - Abstract
Background Most clinicians acknowledge that type 2 diabetes is multifactorial and has heterogeneous characteristics, but neither prevention nor treatment is systematically stratified. To address the heterogeneity of the disease, we examined whether patients diagnosed on the basis of fasting glucose concentrations, those diagnosed on the basis of 2 h concentrations, and those diagnosed on the basis of both criteria differed in terms of pathogenesis or cardiovascular risks. Methods Retrospectively, we analysed trajectories of cardiometabolic risk factors and 10 year cardiovascular risks in the prospective Whitehall II study cohort by use of multilevel longitudinal modelling. Participants were diagnosed by 75 g oral glucose-tolerance tests. We classified those diagnosed with type 2 diabetes into three subgroups: diagnosed on the basis of fasting glucose concentrations, diagnosed on the basis of 2 h glucose concentrations, and diagnosed on the basis of both concentrations. We also developed a classification tree for identification of individuals who are likely to have high fasting and 2 h glucose concentrations, but for whom only fasting concentrations are available. Results Median follow-up was 14-2 years with 15826 person-examinations (1991-2009). Of 10 308 individuals, 6843 were included and 6569 remained diabetes free. 274 cases of type 2 diabetes were identified: 55 had high fasting glucose concentrations only, 148 had high 2 h concentrations only, and 71 had high fasting and 2 h concentrations. At diagnosis, participants with high fasting and 2 h glucose concentrations had higher mean body-mass indices (30.9 kg/m² [SD 5.7]) than did those with high fasting concentrations (28.4 kg/m² [4.4]; p=0.0009) or concentrations (27.9 kg/m² [4.9]; <0.0001). Mean glycated haemoglobin A1c concentrations were also higher in the fasting and 2 h subgroup (7.4% [1.6]) than in the fasting (5.9% [0.5]; <0.0001) or 2 h (5.9% [0.6]; <0.0001) sugroups. Additionally, the fasting and 2 h subgroup had a higher proportion of individuals with moderate or high risk of cardiovascular disease than did the fasting subgroup (p=0 02). A classic pattern of P-cell decompensation before diagnosis was noted only in the fasting and 2 h subgroup. Additionally, glucose concentrations and insulin resistance accelerated more substantially before diagnosis in the fasting and 2 h subgroup than in the fasting subgroup or the 2 h subgroup. Interpretation Patients with type 2 diabetes diagnosed on the basis of increased fasting glucose concentrations or 2 h glucose concentrations, or both, have distinct cardiometabolic risk development before diagnosis. Funding UK Medical Research Council, UK Economic and Social Research Council, British Heart Foundation, UK Health and Safety Executive, UK Department of Health, US National Heart Lung and Blood Institute, US National Institute on Aging, US Agency for Health Care Policy Research, and John D and Catherine T MacArthur Foundation. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
14. Serum 25(OH)D and Type 2 Diabetes Association in a General Population.
- Author
-
Husemoen, Lise Lotte N., Thuesen, Betina H., Fenger, Mogens, Jørgensen, Torben, Glümer, Charlotte, Svensson, Jannet, Ovesen, Lars, Witte, Daniel R., and Linneberg, Allan
- Subjects
TYPE 2 diabetes ,VITAMIN D ,GLUCOSE ,DIABETES ,GLYCOSYLATED hemoglobin - Abstract
OBJECTIVE--This study aimed to examine vitamin D status as a determinant for development of type 2 diabetes and deterioration of glucose homeostasis. RESEARCH DESIGN AND METHODS--A random sample of the general population of Copenhagen, Denmark, was taken as part of the Inter99 study. Included were 6,405 men and women aged 30-65 years at baseline (1999-2001), with 4,296 participating in the follow-up examination 5 years later (2004-2006). Vitamin D was determined at baseline as serum 25-hydroxyvitamin D [25(OH)D]. Diabetes was defined based on an oral glucose tolerance test and a glycosylated hemoglobin (HbA1c) test. Secondary outcomes included continuous markers of glucose homeostasis. RESULTS--The risk of incident diabetes associated with a 10 nmol/L increase in 25(OH)D was odds ratio (OR) 0.91 (95% CI 0.84-0.97) in crude analyses. The association became statistically nonsignificant after adjustment for confounders, with an OR per 10 nmol/L of 0.94 (0.86-1.03). Low 25(OH)D status was significantly associated with unfavorable longitudinal changes in continuous markers of glucose homeostasis after adjustment for confounders. Fasting and 2-h glucose and insulin as well as the degree of insulin resistance increased significantly more during follow-up among those with low 25(OH)D levels compared with those with higher levels. CONCLUSIONS--Low 25(OH)D status was not significantly associated with incident diabetes after adjustment for confounders. However, it was significantly associated with unfavorable longitudinal changes in continuous markers of glucose homeostasis, indicating that low vitamin D status could be related to deterioration of glucose homeostasis. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
15. Associations of Common Genetic Variants With Age-Related Changes in Fasting and Postload Glucose.
- Author
-
Jensen, Anders C., Barker, Adam, Kumari, Meena, Brunner, Eric J., Kivimäki, Mika, Hingorani, Aroon D., Wareham, Nicholas J., Tabák, Adam G., Witte, Daniel R., and Langenberg, Claudia
- Subjects
GLUCOSE ,FASTING ,GLUCOSE tolerance tests ,DIABETES ,GENETIC polymorphisms - Abstract
OBJECTIVE--In the general, nondiabetic population, fasting glucose increases only slightly over time, whereas 2-h postload glucose shows a much steeper age-related rise. The reasons underlying these different age trajectories are unknown. We investigated whether common genetic variants associated with fasting and 2-h glucose contribute to age-related changes of these traits. RESEARCH DESIGN AND METHODS--We studied 5,196 nondiabetic participants of the Whitehall II cohort (aged 40-78 years) attending up to four 5-yearly oral glucose tolerance tests. A genetic score was calculated separately for fasting and 2-h glucose, including 16 and 5 single nucleotide polymorphisms, respectively. Longitudinal modeling with age centered at 55 years was used to study the effects of each genotype and genetic score on fasting and 2-h glucose and their interactions with age, adjusting for sex and time-varying BMI. RESULTS--The fasting glucose genetic score was significantly associated with fasting glucose with a 0.029 mmol/L (95% CI 0.023-0.034) difference (P = 2.76 x 10
-21 ) per genetic score point, an association that remained constant over time (age interaction P = 0.17). Two-hour glucose levels differed by 0.076 mmol/L (0.047-0.105) per genetic score point (P = 3.1 x 10-7 ); notably, this effect became stronger with increasing age by 0.006 mmol/L (0.003-0.009) per genetic score point per year (age interaction P = 30 x 105), resulting in diverging age trajectories by genetic score. CONCLUSIONS--Common genetic variants contribute to the age-related rise of 2-h glucose levels, whereas associations of variants for fasting glucose are constant over time, in line with stable age trajectories of fasting glucose. [ABSTRACT FROM AUTHOR]- Published
- 2011
- Full Text
- View/download PDF
16. The minor C-allele of rs2014355 in ACADS is associated with reduced insulin release following an oral glucose load.
- Author
-
Hornbak, Malene, Banasik, Karina, Justesen, Johanne M., Krarup, Nikolaj T., Sandholt, Camilla H., Andersson, Äsa, Sandbæk, Annelli, Lauritzen, Torsten, Pisinger, Charlotta, Witte, Daniel R., Sørensen, Thorkild I. A., Pedersen, Oluf, and Hansen, Torben
- Subjects
INSULIN ,GLUCOSE ,GENOMES ,COENZYMES ,TYPE 2 diabetes - Abstract
Background: A genome-wide association study (GWAS) using metabolite concentrations as proxies for enzymatic activity, suggested that two variants: rs2014355 in the gene encoding short-chain acyl-coenzyme A dehydrogenase (ACADS) and rs11161510 in the gene encoding medium-chain acyl-coenzyme A dehydrogenase (ACADM) impair fatty acid β-oxidation. Chronic exposure to fatty acids due to an impaired β-oxidation may down-regulate the glucose-stimulated insulin release and result in an increased risk of type 2 diabetes (T2D). We aimed to investigate whether the two variants associate with altered insulin release following an oral glucose load or with T2D. Methods: The variants were genotyped using KASPar® PCR SNP genotyping system and investigated for associations with estimates of insulin release and insulin sensitivity following an oral glucose tolerance test (OGTT) in a random sample of middle-aged Danish individuals (n
ACADS = 4,324; nACADM = 4,337). The T2D-case-control study involved a total of ∼8,300 Danish individuals (nACADS = 8,313; nACADM = 8,344). Results: In glucose-tolerant individuals the minor C-allele of rs2014355 of ACADS associated with reduced measures of serum insulin at 30 min following an oral glucose load (per allele effect (β) = -3.8% (-6.3%;-1.3%), P = 0.003), reduced incremental area under the insulin curve (β = -3.6% (-6.3%;-0.9%), P = 0.009), reduced acute insulin response (β = -2.2% (-4.2%;0.2%), P = 0.03), and with increased insulin sensitivity ISIMatsuda (β = 2.9% (0.5%;5.2%), P = 0.02). The C-allele did not associate with two other measures of insulin sensitivity or with a derived disposition index. The C-allele was not associated with T2D in the case-control analysis (OR 1.07, 95% CI 0.96-1.18, P = 0.21). rs11161510 of ACADM did not associate with any indices of glucose-stimulated insulin release or with T2D. Conclusions: In glucose-tolerant individuals the minor C-allele of rs2014355 of ACADS was associated with reduced measures of glucose-stimulated insulin release during an OGTT, a finding which in part may be mediated through an impaired β-oxidation of fatty acids. [ABSTRACT FROM AUTHOR]- Published
- 2011
- Full Text
- View/download PDF
17. Associations Between Features of Glucose Exposure and A1C.
- Author
-
Borg, Rikke, Kuenen, Judith C., Carstensen, Bendix, Zheng, Hui, Nathan, David M., Heine, Robert J., Nerup, Jorn, Borch-Johnsen, Knut, and Witte, Daniel R.
- Subjects
GLUCOSE ,GLYCEMIC index ,BLOOD sugar ,BLOOD sugar monitoring ,DIABETES - Abstract
OBJECTIVE--Various methods are used to quantify postprandial glycemia or glucose variability, but few have been compared and none are standardized. Our objective was to examine the relationship among common indexes of postprandial glycemia, overall hyperglycemia, glucose variability, and A1C using detailed glucose measures obtained during everyday life and to study which blood glucose values of the day provide the strongest prediction of A1C. RESEARCH DESIGN AND METHODS--In the A1C-Derived Average Glucose (ADAG) study, glucose levels were monitored in 507 participants (268 type 1 diabetic, 159 type 2 diabetic, and 80 nondiabetic subjects) with continuous glucose monitoring (CGM) and frequent serf-monitoring of blood glucose (SMBG) during 16 weeks. We calculated several indexes of glycemia and analyzed their intercorrelations. The association between glucose measurements at different times of the day (pre- and postprandial) and A1C was examined using multiple linear regression. RESULTS--Indexes of glucose variability showed strong inter-correlation. Among postprandial indexes, the area under the glucose curve calculated from CGM 2 h after a meal correlated well with the 90-min SMBG postprandial measurements. Fasting blood glucose (FBG) levels were only moderately correlated with indexes of hyperglycemia and average or postprandial glucose levels. Indexes derived with SMBG strongly correlated with those from CGM. Some SMBG time points had a stronger association with A1C than others. Overall, preprandial glucose values had a stronger association with A1C than postprandial values for both diabetes types, particularly for type 2 diabetes. CONCLUSIONS--Indexes of glucose variability and average and postprandial glycemia intercorrelate strongly within each category. Variability indexes are weakly correlated with the other categories, indicating that these measures convey different information. FBG is not a clear indicator of general glycemia. Preprandial glucose values have a larger impact on A1C levels than postprandial values. Diabetes 59:1585-1590, 2010 [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
18. Relation Between Blood Glucose and Coronary Mortality Over 33 Years in the Whitehall Study.
- Author
-
Brunner, Eric J., Shipley, Martin J., Witte, Daniel R., Fuller, John H., and Marmot, Michael G.
- Subjects
CORONARY disease ,GLUCOSE ,BLOOD sugar ,GLUCOSE tolerance tests ,BLOOD pressure ,BLOOD cholesterol ,SMOKING ,MORTALITY ,DISEASE risk factors - Abstract
OBJECTIVE -- Glucose intolerance is a risk factor for coronary disease, but there is uncertainty about the shape of the dose-response relationship between glucose level and risk of coronary mortality. We examined the prospective relation of 2-h postload blood glucose (2hBG) with coronary and other major causes of mortality over 33 years. RESEARCH DESIGN AND METHODS -- A 50-g oral glucose tolerance test (OGTT) was performed at baseline (1967-1969) in 17,869 male civil servants aged 40-64 years. RESULTS -- There were 3,561 coronary deaths during 451,787 person-years of observation. All-cause, cardiovascular, and respiratory mortality were elevated among participants with glucose intolerance. The hazard of coronary mortality rose from 2hBG = 4.6 mmol/l (83 mg/dl [95% CI 4.2-5.3]). The dose-response relation was best fitted by a single slope above this level, with no evidence of nonlinearity, compared with Cox models using other threshold levels, and those containing log 2hBG terms. There was no evidence for a dose-response relationship below 2hBG = 4.6 mmol/l. Between this level and 11.1 mmol/l (200 mg/dl), the age-adjusted hazard ratio was 3.62 (95% CI 2.3-5.6). The graded relationship was attenuated by 45% after adjustment for baseline coronary heart disease (CHD), BMI, systolic blood pressure, blood cholesterol, smoking, physical activity, lung function, and employment grade. CONCLUSIONS -- A threshold model with linear slope best described the dose-response relationship between postload blood glucose and CHD mortality risk. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
19. Glucose Measurements at Various Time Points During the OGTT and Their Role in Capturing Glucose Response Patterns.
- Author
-
Hulman, Adam, Wagner, Róbert, Vistisen, Dorte, Færch, Kristine, Balkau, Beverley, Manco, Melania, Golay, Alain, Häring, Hans-Ulrich, Heni, Martin, Fritsche, Andreas, and Witte, Daniel R.
- Subjects
GLUCOSE ,TIME measurements - Abstract
The article focuses on the study of intermediate time points during the oral glucose tolerance test (OGTT). It focuses on the characterization of glucose response patterns from OGTTs that offers insights into the heterogeneity of type 2 diabetes development. It focuses on the number of glucose measurements during an OGTT.
- Published
- 2019
- Full Text
- View/download PDF
20. Greater glucagon-like peptide-1 responses to oral glucose are associated with lower central and peripheral blood pressures.
- Author
-
Lundgren, Julie R., Færch, Kristine, Witte, Daniel R., Jonsson, Anna E., Pedersen, Oluf, Hansen, Torben, Lauritzen, Torsten, Holst, Jens J., Vistisen, Dorte, Jørgensen, Marit E., Torekov, Signe S., and Johansen, Nanna B.
- Subjects
BLOOD pressure ,GLUCOSE tolerance tests ,CARDIOVASCULAR system ,GLUCOSE ,REGRESSION analysis - Abstract
Background and aim: Cardiovascular diseases (CVDs) are globally the leading cause of death and hypertension is a significant risk factor. Treatment with glucagon-like peptide-1 (GLP-1) receptor agonists has been associated with decreases in blood pressure and CVD risk. Our aim was to investigate the association between endogenous GLP-1 responses to oral glucose and peripheral and central haemodynamic measures in a population at risk of diabetes and CVD. Methods: This cross-sectional study included 837 Danish individuals from the ADDITION-PRO cohort (52% men, median (interquartile range) age 65.5 (59.8 to 70.7) years, BMI 26.1 (23.4 to 28.5) kg/m
2 , without antihypertensive treatment and known diabetes). All participants received an oral glucose tolerance test with measurements of GLP-1 at 0, 30 and 120 min. Aortic stiffness was assessed by pulse wave velocity (PWV). The associations between GLP-1 response and central and brachial blood pressure (BP) and PWV were assessed in linear regression models adjusting for age and sex. Results: A greater GLP-1 response was associated with lower central systolic and diastolic BP of − 1.17 mmHg (95% confidence interval (CI) − 2.07 to − 0.27 mmHg, P = 0.011) and − 0.74 mmHg (95% CI − 1.29 to − 0.18 mmHg, P = 0.009), respectively, as well as lower brachial systolic and diastolic BP of − 1.27 mmHg (95% CI − 2.20 to − 0.33 mmHg, P = 0.008) and − 1.00 (95% CI − 1.56 to − 0.44 mmHg, P = 0.001), respectively. PWV was not associated with GLP-1 release (P = 0.3). Individuals with the greatest quartile of GLP-1 response had clinically relevant lower BP measures compared to individuals with the lowest quartile of GLP-1 response (central systolic BP: − 4.94 (95% CI − 8.56 to − 1.31) mmHg, central diastolic BP: − 3.05 (95% CI − 5.29 to − 0.80) mmHg, brachial systolic BP: − 5.18 (95% CI − 8.94 to − 1.42) mmHg, and brachial diastolic BP: − 2.96 (95% CI − 5.26 to − 0.67) mmHg). Conclusion: Greater glucose-stimulated GLP-1 responses were associated with clinically relevant lower central and peripheral blood pressures, consistent with beneficial effects on the cardiovascular system and reduced risk of CVD and mortality. Trial registration ClinicalTrials.gov Identifier: NCT00237549. Retrospectively registered 10 October 2005 [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
21. Antidepressant Medication Use and Risk of Hyperglycemia and Diabetes Mellitus—A Noncausal Association?
- Author
-
Kivimäki, Mika, Batty, G. David, Jokela, Markus, Ebmeier, Klaus P., Vahtera, Jussi, Virtanen, Marianna, Brunner, Eric J., Tabak, Adam G., Witte, Daniel R., Kumari, Meena, Singh-Manoux, Archana, and Hamer, Mark
- Subjects
- *
ANTIDEPRESSANTS , *HYPERGLYCEMIA , *DIABETES , *ETIOLOGY of diseases , *BLOOD sugar monitoring , *GLUCOSE tolerance tests , *CONFIDENCE intervals - Abstract
Background: Previous research suggests a link between antidepressant use and diabetes, but it is unclear whether the association is causal or attributable to detection/ascertainment bias. To examine this, we assessed the associations of antidepressant use with change in glucose levels and incidence of undiagnosed and diagnosed diabetes. Methods: During an 18-year period, we monitored antidepressant use, glucose levels, and diabetes status in 5978 civil servants (70.9% male, age range 39–64 years) free of diabetes at baseline (the Whitehall II study). Use of medication and plasma glucose were assessed at four study screenings: 1991/1993, 1997/1999, 2003/2004, and 2008/2009. Incident diabetes cases were classified as either diagnosed (n = 294) if detected using self-report of physician diagnosis and/or the use of diabetes medication or undiagnosed (n = 346) if detected based on fasting and/or 2-hour postload glucose levels using an oral glucose tolerance test at the study screenings. Results: Incidence of diagnosed diabetes was higher among antidepressant users than nonusers (odds ratio 3.10, 95% confidence interval: 1.66–5.78). However, antidepressant use was not associated with undiagnosed diabetes at any follow-up examination nor with higher fasting or 2-hour postload plasma glucose levels or increasing glucose levels over time. Odds ratio for undiagnosed diabetes for antidepressant users versus nonusers was .88 (95% confidence interval: .45–1.72, p = .70). The mean difference in glucose changes between participants reporting antidepressant use at three screenings compared with those not on antidepressant treatment was .0 mmol/L. Conclusions: The link between antidepressant use and diabetes risk may not be causal in nature. [Copyright &y& Elsevier]
- Published
- 2011
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.